New adaptive radiation aims to spare bladder in prostate cancer patients
NCT ID NCT06834152
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new type of radiation therapy that adapts to changes in the prostate and bladder during each treatment session. It is for men with localized prostate cancer who also have an enlarged prostate or urinary symptoms. The goal is to see if this approach can reduce severe urinary side effects while still controlling the cancer. The trial will enroll 75 participants across multiple centers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy (adaptive stereotactic body radiotherapy)
What this could lead to
If successful, this approach could offer a safer, more precise radiation option for prostate cancer patients with urinary issues, reducing severe side effects.
What could go wrong
This is a small, early-phase study (75 participants) focused on safety and feasibility. The treatment may still cause significant urinary or bowel side effects, and it is not yet proven to be better than standard radiation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Klinik für Radioonkologie und Strahlentherapie, Universitätsklinikum Heidelberg
NOT_YET_RECRUITINGHeidelberg, Baden-Wurttemberg, 69120, Germany
Contact Email: •••••@•••••
Contact
-
Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Universitätsklinikum LMU
NOT_YET_RECRUITINGMunich, Bavaria, 81377, Germany
Contact Email: •••••@•••••
Contact
-
University Hospital Zurich, Department of Radio-Oncology
RECRUITINGZurich, Canton of Zurich, 8090, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact